Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Lucira Health
About
  2. Companies
  3. Lucira Health
  4. Products
  5. Lucira - Molecular COVID-19 Testing

Lucira - Molecular COVID-19 Testing

SHARE
The Lucira Check It is a molecular or nucleic acid amplification test (NAAT) that provides accurate, at-home results for the detection of the COVID-19 virus. Our tests have an analytical sensitivity (ability to detect the SARS-CoV-2 virus) that is comparable to some of the best performing PCR tests in clinical settings and high complexity labs. To ensure the validity and accuracy of Lucira’s COVID-19 Test Kit, several studies were conducted to compare our tests against one of the most sensitive PCR tests authorized by the FDA.
Most popular related searches
COVID-19 test
COVID-19 test kit
COVID 19
COVID testing
sars-cov-2
COVID kit
clinical study
genetic material
COVID-19 home test
molecular test-kit
If SARS-CoV-2 is present in a sample, Lucira’s innovative platform is designed to find it and amplify the virus’s genetic material while the test is running, just like PCR lab tests. In the clinical studies described below, Lucira’s amplification method provides a level of accuracy comparable to one of the highest sensitivity lab PCR tests.
 
In two Community Testing Studies which included individuals with and without COVID-19 symptoms, the Lucira COVID-19 test was compared to the Hologic Panther Fusion, one of the highest sensitivity FDA authorized SARS-CoV-2 PCR tests.
Lucira achieved 98% accuracy, 97% positive percent agreement (PPA) and 98% negative percent agreement (NPA)1, excluding samples with very low levels of virus that possibly no longer reflected active infection2. Across all data and including 10 samples with very low viral loads (>37.5 Ct), Lucira achieved 96% accuracy, 92% PPA, and 98% NPA3.
To further validate the results of Lucira’s COVID-19 test kit, study participants swabbed themselves twice—once for the Lucira test and again for a well-known, high sensitivity PCR test. Then, we compared the Lucira test results to the PCR test results.
 
Positive Percent Agreement (PPA), or sensitivity, represents how often the Lucira test agreed with the comparator PCR’s positive test results. Negative Percent Agreement (NPA), or specificity, represents how often the Lucira test agreed with the comparator PCR’s negative test results.
Start testing and stop worrying with Lucira’s Check It COVID-19 Testing Kit. From the comfort of your home, the results you need are just a swab away.
 
Lucira COVID-19 Test Kits are available for both consumer purchase, as well as for enterprise. In just 30 minutes, our easy-to-use tests give you the results you need so you can make informed decisions.
 
Click the links below to order accurate, at-home molecular COVID-19 test kits.